Centenial Surgical Suture Fair Value
Centenial Surgical Suture (CSURGSU) average fair value is ₹1941.86 across 4 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF), vs a current market price of ₹94.0 (+1965.81%), fair value range ₹62.0–₹6963.02. See Centenial Surgical Suture P/B ratio trends to compare market price against book value per share.
Fair Value Analysis Export
CSURGSU Fair Value vs Current Price — Valuation Summary
CSURGSU average fair value, fair value range, price gap and valuation status across 4 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF). For live price and a broader fundamental view, visit Centenial Surgical Suture share price today.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Discounted Cash Flow (DCF)
CSURGSU Fair Value Analysis — Data Sources & Coverage
Centenial Surgical Suture financial data sources, valuation methods applied and sector benchmarks used. Also explore CSURGSU price movement history to track price trends across different timeframes.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
CSURGSU vs Healthcare Sector Peers — P/E, P/B & Market Cap
Centenial Surgical Suture P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Accretion Pharmaceuticals | ACCPL | 17.91 | 2.7 | ₹120 |
| Jeena Sikho Lifecare | JSLL | 40.38 | 23.07 | ₹7,944 |
| Par Drugs & Chemical | PAR | 8.2 | 0.96 | ₹103 |
| Aurobindo Pharma | AUROPHARMA | 25.16 | 2.5 | ₹87,806 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.